TrialBMC cancer2023

Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.

Joseph Kauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.